- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Pomalidomide – March 2017
Pomalidomide: Capsule 3 mg, Capsule 4 mg; Pomalyst®
Last updated
14 July 2017